Phase II combination of lirilumab and nivolumab with 5-azacitidine in patients with myelodysplastic syndromes (MDS)
The goal of this clinical research study is to learn if lirilumab and Opdivo (nivolumab), alone or in combination with Vidaza (azacitidine), can help to control MDS. The safety of these drug combinations will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 03/21/2016
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: